Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Endocr Pract. 2011 Sep 1;17(5):753–758. doi: 10.4158/EP11027.OR

Table 2.

Study Data

Total
N=82
50%
N=28
65%
N=29
80%
N=25
P-value
Final 6 hour IV insulin dose (units) 14.2 (11.5) 17.0 (17) 12.7 (7.4) 12.8 (7.6) 0.28
Initial Detemir dose (units) 35 (18) 33 (19) 32 (13) 41 (21) 0.17
24 hour total insulin (units) 66 (27) 66 (34) 61 (18) 71 (27) 0.42
24 hour carbohydrate intake (grams) 128 (77) 119 (78) 122 (70) 144 (84) 0.48
Reversion to insulin infusion (%) 3 (4%) 2 (7%) 0 1 (4%) NA
% basal insulin overall 0.68 (0.15) 0.67 (0.16) 0.68 (0.15) 0.70 (0.15) 0.76
Morning glucose
Day 1 Mean (mg/dl) 139 (47) 144 (48) 141 (51) 130 (31) 0.49
 % at target (80–130 mg/dl) 42 (51%) 10 (36%) 18 (63%) 14 (56%) 0.12
3-Day Mean (mg/dl) 110 (20) 105 (30) 112 (24) 0.72
 % at target (80–130 mg/dl) 53 (65%) 18 (64%) 20 (69%) 15 (60%) 0.79
Total glucose
Day 1 Mean (mg/dl) 154 (44) 154 (49) 156 (45) 150 (40) 0.89
 % at target (80–180 mg/dl) 60 (73%) 21 (75%) 20 (69%) 19 (76%) 0.70
3-day Mean (mg/dl) 138 (31) 142 (36) 135 (29) 138 (29) 0.70
 % at target (80–180 mg/dl) 74 (90%) 24 (86%) 27 (93%) 23 (92%) 0.60
Hypoglycemia*
 Day 1 2 (2.4%) 0 1 (3.5%) 2 (8%) NA
 Overall 9 (11%) 0 6 (21%) 3 (12%) 0.02
 <40 mg/dl Overall 1 (1.2%) 0 0 1 (4%) NA

Data are presented as mean (standard deviation) or number (%).

*

The 65 and 80% groups are collapsed and compared to the 50% group using Fisher’s exact test for the race variable due to insufficient cell counts.